The page is the record's research on the issuer — no analyst, no rating, no view. # Regencell Bioscience Holdings Ltd (NASDAQ: RGC) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Regencell Bioscience Holdings Ltd, listed on NASDAQ under the ticker RGC, with ISIN USG7487R1008. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-E9. The security type is recorded as non-operating entity type (other), the sector as 2833 Medicinal Chemicals & Botanical Products, and the jurisdiction as the Cayman Islands. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 21 filings in the window from 2025-11-08 to 2026-11-08, across 9 filing days: 9 directors' dealings, 3 prospectuses and 9 results. The median gap between filing days is 15.0 days. The latest filing is a results filing dated 2026-10-07, which is 32 days before the record date of 2026-11-08, and the median latency for the issuer is therefore 32 days. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4,359 issuers. The sector median for 2833 Medicinal Chemicals & Botanical Products is 40.0 filings, a cadence gap of 7.2 days and a latency of 4.5 days across 18 issuers. The issuer's 21 filings are below both medians. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable for the US chapter. The orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years for the issuer for 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001829667.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/RGC (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/RGC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RGC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp